Cartesian Therapeutics (RNAC) Depreciation and Depletion (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Depreciation and Depletion of $600000.0 for Q1 2026, little changed year-over-year from $600000.0 in Q1 2025, and little changed quarter-over-quarter from $600000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Depreciation and Depletion (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Depreciation and Depletion data on file, last reported at $600000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $600000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 50.0% YoY), and the FY2025 annual result was $2.4 million, up 100.0% from the prior year.
- Depreciation and Depletion held at $600000.0 in Q1 2026 per RNAC's latest filing, from $600000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $600000.0 in Q1 2025 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $329411.8 and a median of $200000.0 in 2022 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2023 and 2024: Depreciation and Depletion plunged 50.0% in 2023, then jumped 200.0% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $200000.0 in 2022, then changed by 0.0% to $200000.0 in 2023, then surged by 150.0% to $500000.0 in 2024, then increased by 20.0% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
- Business Quant data shows RNAC's Depreciation and Depletion at $600000.0 in Q1 2026, $600000.0 in Q4 2025, and $600000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |